Cutaneous T‐cell lymphoma: 2017 update on diagnosis, risk‐stratification, and management

RA Wilcox - American journal of hematology, 2017 - Wiley Online Library
Disease overview Cutaneous T‐cell lymphomas are a heterogenous group of T‐cell
lymphoproliferative disorders involving the skin, the majority of which may be classified as …

Mycosis fungoides and Sézary syndrome: 2019 update on diagnosis, risk‐stratification, and management

AC Hristov, T Tejasvi, RA Wilcox - American journal of …, 2019 - Wiley Online Library
Abstract Disease Overview Cutaneous T‐cell lymphomas (CTCL) are a heterogenous group
of T‐cell neoplasms involving the skin, the majority of which may be classified as Mycosis …

Guidelines on the Use of therapeutic apheresis in clinical practice–Evidence‐Based approach from the Writing Committee of the American Society for Apheresis: The …

L Connelly‐Smith, CR Alquist, NA Aqui… - Journal of clinical …, 2023 - Wiley Online Library
Abstract The American Society for Apheresis (ASFA) Journal of Clinical Apheresis (JCA)
Special Issue Writing Committee is charged with reviewing, updating, and categorizing …

Guidelines on the use of therapeutic apheresis in clinical practice–evidence‐based approach from the Writing Committee of the American Society for Apheresis: the …

A Padmanabhan, L Connelly‐Smith… - Journal of clinical …, 2019 - Wiley Online Library
ABSTRACT The American Society for Apheresis (ASFA) Journal of Clinical Apheresis (JCA)
Special Issue Writing Committee is charged with reviewing, updating and categorizing …

Cutaneous T‐cell lymphomas: 2023 update on diagnosis, risk‐stratification, and management

AC Hristov, T Tejasvi, RA Wilcox - American journal of …, 2023 - Wiley Online Library
Abstract Disease Overview Cutaneous T‐cell lymphomas are a heterogenous group of T‐
cell neoplasms involving the skin, the majority of which may be classified as Mycosis …

Mycosis fungoides and Sézary syndrome: an update

C Larocca, T Kupper - Hematology/Oncology Clinics, 2019 - hemonc.theclinics.com
Cutaneous T-cell lymphomas (CTCLs) encompass a heterogeneous collection of non-
Hodgkin lymphomas that arise from skin-tropic memory T lymphocytes. Among them …

[图书][B] Skin lymphoma: the illustrated guide

L Cerroni - 2020 - books.google.com
A complete guide to the diagnosis and management of cutaneous lymphomas and
pseudolymphomas Easily misdiagnosed as benign skin diseases, malignant cutaneous …

International study of treatment efficacy in SS shows superiority of combination therapy and heterogeneity of treatment strategies

BA Campbell, G Dobos, Z Haider, HM Prince… - Blood …, 2023 - ashpublications.org
Despite increasing availability of therapies, patients with Sezary syndrome (SS) commonly
endure multi-line treatment journeys, mostly with partial responses of short duration …

Time to next treatment as a meaningful endpoint for trials of primary cutaneous lymphoma

BA Campbell, JJ Scarisbrick, YH Kim, RA Wilcox… - Cancers, 2020 - mdpi.com
Time to next treatment (TTNT) is an emerging endpoint in clinical studies of primary
cutaneous T-cell lymphomas (CTCL), with utility as a surrogate marker for the “duration of …

Current status of HDAC inhibitors in cutaneous T-cell lymphoma

AT Lopez, S Bates, L Geskin - American journal of clinical dermatology, 2018 - Springer
Cutaneous T-cell lymphomas (CTCLs) are a heterogeneous group of lymphomas that are
characterized by primary skin involvement. Mycosis fungoides (MF) and Sézary syndrome …